Evidence map›Paper›PMID 30707354›Full record

ReviewNeurotoxicity research2019

The Role of PI3K/Akt and ERK in Neurodegenerative Disorders.

Sachchida Nand Rai, Hagera Dilnashin, Hareram Birla, Saumitra Sen Singh, Walia Zahra, Aaina Singh Rathore, Brijesh Kumar Singh, Surya Pratap Singh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurotoxicity research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 256 papers.

0numbers the graph read from it
0cells of the map it votes in
256citing papers in PubMed
23.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

256 citing papers in PubMed, 481 citations in OpenAlex.

  1. Article
  2. International journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Microglial HVCN1 Deficiency Improves Movement and Survival of SOD1Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  13. Unravelling the novel insights between miR-7 and Parkinson's disease (PD).Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. BDCD: a comprehensive Brain Disease Cell-cell communication Database.Database : the journal of biological databases and curation · 2026
    Article
  20. Article

196 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Sachchida Nand RaiDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Hagera DilnashinDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Hareram BirlaDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Saumitra Sen SinghDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Walia ZahraDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Aaina Singh RathoreDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India.
Brijesh Kumar SinghDepartment of Pathology and Cell Biology, Columbia University Medical Centre, Columbia University, New York, NY, 10032, USA.
Surya Pratap SinghDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, 221005, India. suryasinghbhu16@gmail.com.
Banaras Hindu University · INColumbia University Irving Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disruption of Akt and Erk-mediated signal transduction significantly contributes in the pathogenesis of various neurodegenerative diseases (NDs), such as Parkinson's disease, Alzheimer's diseases, Huntington's disease, and many others. These regulatory proteins serve as the regulator of cell survival, motility, transcription, metabolism, and progression of the cell cycle. Therefore, targeting Akt and Erk pathway has been proposed as a reasonable approach to suppress ND progression. This review has emphasized on involvement of Akt/Erk cascade in the neurodegeneration. Akt has been reported to regulate neuronal toxicity through its various substrates like FOXos, GSK3β, and caspase-9 etc. Akt is also involved with PI3K in signaling pathway to mediate neuronal survival. ERK is another kinase which also regulates proliferation, differentiation, and survival of the neural cell. There has also been much progress in developing a therapeutic molecule targeting Akt and Erk signaling. Therefore, improved understanding of the molecular mechanism behind the regulatory aspect of Akt and Erk networks can make strong impact on exploration of the neurodegenerative disease pathogenesis.

Indexed as

AnimalsExtracellular Signal-Regulated MAP KinasesHumansNeurodegenerative DiseasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktExtracellular Signal-Regulated MAP KinasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt6-OHDA, 6-hydroxydopamineBDNF, brain-derived neurotrophic factorHD, Huntington diseaseMAPK, mitogen-activated protein-extracellular kinaseMPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineNDs, neurodegenerative disordersNrf2, nuclear factor erythroid 2 p45-related factor 2PD, Parkinson’s disease

Identifiers

PMID30707354
OpenAlexW2911286776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.